It was the worlds first PEGylated long-acting GLP-1RA
ABSTRACT Glucagon-like peptide-1 (GLP-1) is a member of the proglucagon incretin family, and GLP-1 receptor agonists (RAs) have been introduced as a new class of antidiabetic medications in the past decade
Therefore, we used an empirical approach to quantify allosterism
YY, , GLP-1
10.1038/s41598-020-75621-5 Summary Keywords incretinbased therapy, GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), T2D (type 2 diabetes), obesity, incretin receptors Citation Austin GO and Tomas A (2023) Variation in responses to incretin therapy: Modifiable and non-modifiable factors
Program costs vary based on the medication prescribed, your insurance coverage, and the level of support included